Tenaya Therapeutics (TNYA)Officer sold ~$655
Tomohiro Higa, Officer at Tenaya Therapeutics, sold ~$655 of Tenaya Therapeutics shares.
- ~$655
- Approx. value · 523 sh @ $1.25
- 98K
- Holds after · shares reported
- Traded
- Aug 18, 2025
- Filed
- Aug 19, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 18, 2025 · this disclosureInsiderOfficer sold ~$655 of TNYA shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Tenaya Therapeutics
OQRO holds no insider, Congress, fund or contract record for Tenaya Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TNYA page.
Other recent filings by Tomohiro Higa, SVP, Finance
- SEC Form 4 at Tenaya Therapeutics (TNYA)Aug 19, 2025
- SEC Form 4 at Tenaya Therapeutics (TNYA)Aug 19, 2025
- SEC Form 4 at Tenaya Therapeutics (TNYA)May 16, 2025
- SEC Form 4 at Tenaya Therapeutics (TNYA)Mar 11, 2025
- SEC Form 4 at Tenaya Therapeutics (TNYA)Mar 11, 2025
The full history of Tomohiro Higa, SVP, Finance is on the profile page.
How this filing works
Other disclosures at Tenaya Therapeutics
- SEC Form 4Aug 19, 2025
- SEC Form 4Aug 19, 2025
- SEC Form 4Aug 19, 2025
- SEC Form 4Aug 19, 2025
- SEC Form 4Aug 19, 2025
- SEC Form 4Aug 19, 2025
Everything OQRO holds on this company is on its TNYA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data